SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DaiS who wrote (13233)8/13/1998 6:07:00 PM
From: DAVID  Read Replies (1) of 23519
 
DaiS

<<These two posts give what I know about the gene therapy work
Message 5319236
Message 5416846;

Excellent posts. If the gene therapy does work well, can anyone guess as to: 1) when clinicals might start, 2) how long would they take to complete, 3) what the clinicals might cost to do, 4) the cost of an injection every two months of an approved drug, and 5) the cost of the manufactured dose vivus would bear.

I know those are hard questions to answer. I'm trying to figure them out myself.

Does Vivus have the exclusive rights to the work done by the Albert E. researches ? Does anyone know the working arrangements ?

DAVID
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext